tiprankstipranks
Longevity Health Holdings (XAGE)
OTHER OTC:XAGE
US Market
XAGE
Longevity Health Holdings
RESEARCH TOOLSreports
Want to see XAGE full AI Analyst Report?

Longevity Health Holdings (XAGE) Ratios

97 Followers

Longevity Health Holdings Ratios

XAGE's free cash flow for Q4 2025 was $0.67. For the 2025 fiscal year, XAGE's free cash flow was decreased by $ and operating cash flow was $-4.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.25 0.25 0.16 1.63 0.08
Quick Ratio
 0.12 0.12 0.14 1.63 0.08
Cash Ratio
 0.09 0.09 0.03 0.08 0.02
Solvency Ratio
 -0.81 -0.81 -1.64 -0.39 -0.22
Operating Cash Flow Ratio
 -0.42 -0.42 -0.75 -0.22 -0.47
Short-Term Operating Cash Flow Coverage
 -17.53 -17.53 -18.20 -6.48 -1.23
Net Current Asset Value
$ -6.28M$ -6.28M$ -5.23M$ 23.70M$ -38.93M
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.21 0.43 0.03 2.14
Debt-to-Equity Ratio
 -0.09 -0.09 -0.14 0.09 -0.10
Debt-to-Capital Ratio
 -0.09 -0.09 -0.16 0.08 -0.11
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 -0.40 -0.40 -0.31 2.58 -0.05
Debt Service Coverage Ratio
 -32.05 -32.05 -35.86 -6.98 -0.78
Interest Coverage Ratio
 -390.23 -390.23 -101.98 -5.87 -1.47
Debt to Market Cap
 0.40 0.37 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.30 0.30 0.03 0.15 0.38
Net Debt to EBITDA
 0.03 0.03 -0.05 0.05 -0.71
Profitability Margins
Gross Profit Margin
57.23%57.23%87.37%0.00%0.00%
EBIT Margin
-358.15%-358.15%-21262.23%0.00%0.00%
EBITDA Margin
-346.91%-346.91%-20870.20%0.00%0.00%
Operating Profit Margin
-371.58%-371.58%-9933.82%0.00%0.00%
Pretax Profit Margin
-359.11%-359.11%-21359.64%0.00%0.00%
Net Profit Margin
-361.00%-361.00%-20605.47%0.00%0.00%
Continuous Operations Profit Margin
-361.00%-361.00%-21166.31%0.00%0.00%
Net Income Per EBT
100.53%100.53%96.47%95.31%100.00%
EBT Per EBIT
96.64%96.64%215.02%310.61%164.34%
Return on Assets (ROA)
-291.73%-291.73%-703.42%-24.15%-517.65%
Return on Equity (ROE)
158.86%117.70%220.01%-62.41%23.95%
Return on Capital Employed (ROCE)
128.08%128.08%113.53%-20.50%99.30%
Return on Invested Capital (ROIC)
135.02%135.02%121.59%-19.41%208.67%
Return on Tangible Assets
-293.60%-293.60%-712.92%-24.16%-526.29%
Earnings Yield
-1288.95%-1332.22%-5.93%-0.65%-0.15%
Efficiency Ratios
Receivables Turnover
 52.41 52.41 0.16 0.00 0.00
Payables Turnover
 0.18 0.18 <0.01 0.03 0.11
Inventory Turnover
 0.85 0.85 0.06 0.00 0.00
Fixed Asset Turnover
 4.76 4.76 0.10 0.00 0.00
Asset Turnover
 0.81 0.81 0.03 0.00 0.00
Working Capital Turnover Ratio
 -0.38 -0.35 <0.01 0.00 0.00
Cash Conversion Cycle
 -1.57K -1.57K -224.54K -12.92K -3.22K
Days of Sales Outstanding
 6.96 6.96 2.22K 0.00 0.00
Days of Inventory Outstanding
 429.69 429.69 6.24K 0.00 0.00
Days of Payables Outstanding
 2.01K 2.01K 233.00K 12.92K 3.22K
Operating Cycle
 436.65 436.65 8.46K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.93 -1.93 -0.21 -0.40 -0.17
Free Cash Flow Per Share
 -1.94 -1.94 -0.21 -0.40 -0.17
CapEx Per Share
 <0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -234.06 -234.04 0.00 -273.98 -478.60
Capital Expenditure Coverage Ratio
 -234.06 -234.04 0.00 -273.98 -478.60
Operating Cash Flow Coverage Ratio
 -6.66 -6.66 -6.87 -3.91 -0.92
Operating Cash Flow to Sales Ratio
 -1.74 -1.74 -87.22 0.00 0.00
Free Cash Flow Yield
-752.01%-645.05%-2.51%-0.35%-0.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.08 -0.08 -16.88 -153.72 -649.99
Price-to-Sales (P/S) Ratio
 0.25 0.27 3.48K 0.00 0.00
Price-to-Book (P/B) Ratio
 -0.10 -0.09 -37.13 95.93 -155.68
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.14 -0.16 -39.87 -283.37 -1.71K
Price-to-Operating Cash Flow Ratio
 -0.17 -0.16 -39.87 -284.41 -1.72K
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.52 -3.20 -0.14
Price-to-Fair Value
 -0.10 -0.09 -37.13 95.93 -155.68
Enterprise Value Multiple
 -0.04 -0.05 -16.71 -156.24 -1.16K
Enterprise Value
 237.74K 311.47K 175.46M 2.37B 5.89B
EV to EBITDA
 -0.04 -0.05 -16.71 -156.24 -1.16K
EV to Sales
 0.12 0.16 3.49K 0.00 0.00
EV to Free Cash Flow
 -0.07 -0.09 -39.98 -283.28 -1.71K
EV to Operating Cash Flow
 -0.07 -0.09 -39.98 -284.31 -1.72K
Tangible Book Value Per Share
 -3.41 -3.41 -0.23 1.19 -1.91
Shareholders’ Equity Per Share
 -3.41 -3.41 -0.23 1.19 -1.91
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 <0.01 0.00 0.00
Revenue Per Share
 1.11 1.11 <0.01 0.00 0.00
Net Income Per Share
 -4.01 -4.01 -0.50 -0.74 -0.46
Tax Burden
 1.01 1.01 0.96 0.95 1.00
Interest Burden
 1.00 1.00 1.00 1.06 1.71
Research & Development to Revenue
 0.40 0.41 20.95 0.00 0.00
SG&A to Revenue
 3.83 3.83 77.60 0.00 0.00
Stock-Based Compensation to Revenue
 0.26 0.36 16.44 0.00 0.00
Income Quality
 0.48 0.48 0.37 0.54 0.38
Currency in USD